Dr. Atul Kumar earned a medical degree from Temple University School of Medicine, Philadelphia, Pennsylvania, and completed ...

In an interview with Targeted Oncology, Courtney Van Houzen, PharmD, shared her experience in bringing bispecific antibody ...

An update from Acrivon Therapeutics, Inc. ( (ACRV) ) is now available. Acrivon Therapeutics has initiated a Phase 1 clinical ...

The upgrades add to the PAXgene Urine Liquid Biopsy Set recently launched by PreAnalytiX, QIAGEN’s joint venture with BD. The new set, which will be commercialized by QIAGEN, enables reliable analysis ...

Renaissance Technologies LLC trimmed its holdings in Pyxis Oncology, Inc. (NASDAQ:PYXS – Free Report) by 34.5% in the second quarter, Holdings Channel.com reports. The institutional investor owned 96, ...

Aprea Therapeutics, Inc. (Nasdaq: APRE) is set to present four significant abstracts at the EORTC-NCI-AACR Symposium on ...

Investors might want to bet on Elevation Oncology, Inc. (ELEV), as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This rating change essentially reflects an upward trend in earnings ...

New York City-based NYU Langone has named Shridar Ganesan, MD, PhD, as director of the Perlmutter Cancer Center's new Center for Molecular Oncology. In collaboration with teams across NYU Langone, Dr.

Targeted Oncology is pleased to announce that this year’s second recipient is an individual who has showcased outstanding leadership and a profound dedication to enhancing cancer care and actively ...

Discover Cardiff Oncology's promising results with Onvansertib for RAS-mutated colorectal cancer, potentially leading to ...

The theme of our inaugural regional Institute for Value-Based Medicine® event in Boston was, “Elevating Value in Cancer Care, ...